Analysts Set Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Price Target at $5.53
Analysts Set Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Price Target at $5.53
Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Rating) have earned an average recommendation of "Moderate Buy" from the ten research firms that are currently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, four have given a buy rating and one has issued a strong buy rating on the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $5.33.
据Marketbeats报道，目前追踪Aveanna Healthcare Holdings Inc.的十家研究公司对Aveanna Healthcare Holdings Inc.(纳斯达克代码：AVAH-GET)的股票平均推荐为“适度买入”。一名投资分析师对该股的评级为卖出，两名分析师给予持有评级，四名分析师给予买入评级，一名分析师对该公司发出了强烈的买入评级。在去年更新了该股覆盖范围的经纪商中，12个月目标价的平均水平为5.33美元。
AVAH has been the subject of a number of research reports. Raymond James lowered their price target on Aveanna Healthcare from $8.00 to $6.00 and set a "strong-buy" rating for the company in a research report on Monday, August 15th. Barclays lowered their price target on Aveanna Healthcare from $7.00 to $5.00 and set an "overweight" rating for the company in a research report on Friday, August 19th. Truist Financial cut Aveanna Healthcare from a "buy" rating to a "hold" rating and set a $2.50 price objective on the stock. in a research note on Tuesday, July 5th. Stephens reduced their price objective on Aveanna Healthcare to $2.75 in a research note on Friday, July 22nd. Finally, Credit Suisse Group reduced their price objective on Aveanna Healthcare to $5.50 in a research note on Friday, July 22nd.
Avah已经成为许多研究报告的主题。雷蒙德·詹姆斯在8月15日(星期一)的一份研究报告中将Aveanna Healthcare的目标价从8.00美元下调至6.00美元，并为该公司设定了“强力买入”评级。巴克莱在8月19日周五的一份研究报告中将Aveanna Healthcare的目标价从7.00美元下调至5.00美元，并对该公司设定了“增持”评级。Truist Financial将Aveanna Healthcare的评级从“买入”下调至“持有”，并为该股设定了2.50美元的目标价。在7月5日星期二的一份研究报告中。斯蒂芬斯在7月22日星期五的一份研究报告中将Aveanna Healthcare的目标价下调至2.75美元。最后，瑞士信贷集团在7月22日星期五的一份研究报告中将Aveanna Healthcare的目标价下调至5.50美元。
Institutional Inflows and Outflows
机构资金流入和流出
Several institutional investors have recently modified their holdings of AVAH. Qube Research & Technologies Ltd raised its stake in Aveanna Healthcare by 38.7% during the fourth quarter. Qube Research & Technologies Ltd now owns 42,169 shares of the company's stock valued at $312,000 after buying an additional 11,762 shares in the last quarter. Arizona State Retirement System acquired a new stake in Aveanna Healthcare during the fourth quarter valued at approximately $92,000. Envestnet Asset Management Inc. raised its stake in Aveanna Healthcare by 33.8% during the fourth quarter. Envestnet Asset Management Inc. now owns 22,794 shares of the company's stock valued at $169,000 after buying an additional 5,758 shares in the last quarter. Northern Trust Corp raised its stake in Aveanna Healthcare by 3.4% during the fourth quarter. Northern Trust Corp now owns 379,266 shares of the company's stock valued at $2,807,000 after buying an additional 12,440 shares in the last quarter. Finally, Swiss National Bank acquired a new stake in Aveanna Healthcare during the fourth quarter valued at approximately $750,000. Institutional investors and hedge funds own 95.00% of the company's stock.
几家机构投资者最近调整了对Avah的持股。Qube Research&Technologies Ltd在第四季度将其在Aveanna Healthcare的持股增加了38.7%。Qube Research&Technologies Ltd现在拥有42,169股该公司股票，价值312,000美元，上个季度又购买了11,762股。亚利桑那州退休系统在第四季度收购了Aveanna Healthcare的新股份，价值约92,000美元。Envestnet Asset Management Inc.在第四季度将其在Aveanna Healthcare的持股增加了33.8%。Envestnet Asset Management Inc.现在持有22,794股该公司股票，价值16.9万美元，该公司在上个季度又购买了5,758股。北方信托公司在第四季度将其在Aveanna Healthcare的持股增加了3.4%。Northern Trust Corp目前持有379,266股该公司股票，价值2,807,000美元，此前该公司在上个季度又购买了12,440股。最后，瑞士国家银行在第四季度收购了Aveanna Healthcare的新股份，价值约75万美元。机构投资者和对冲基金持有该公司95.00%的股票。
Aveanna Healthcare Price Performance
Aveanna医疗保健价格表现
Aveanna Healthcare (NASDAQ:AVAH – Get Rating) last announced its quarterly earnings data on Wednesday, August 10th. The company reported $0.03 EPS for the quarter, missing analysts' consensus estimates of $0.06 by ($0.03). Aveanna Healthcare had a negative net margin of 33.32% and a positive return on equity of 9.57%. During the same period in the previous year, the company posted $0.08 earnings per share. Equities research analysts forecast that Aveanna Healthcare will post 0.16 EPS for the current year.
Aveanna Healthcare(纳斯达克：AVA-GET评级)最近一次公布季度收益数据是在8月10日星期三。该公司公布本季度每股收益为0.03美元，低于分析师普遍预期的0.06美元(0.03美元)。Aveanna Healthcare的净利润率为负33.32%，股本回报率为正9.57%。去年同期，该公司公布的每股收益为0.08美元。股票研究分析师预测，Aveanna Healthcare本年度每股收益将达到0.16股。
About Aveanna Healthcare
关于Aveanna Healthcare
(Get Rating)
(获取评级)
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals.
Aveanna Healthcare Holdings Inc是一家多元化的家庭护理平台公司，在美国提供私人值班护理(PDN)、成人家庭健康和临终关怀、家庭儿科治疗和肠内营养服务。其以患者为中心的护理交付平台允许患者留在家里，并最大限度地减少对医院等高成本护理机构的过度利用。
See Also
另请参阅
- Get a free copy of the StockNews.com research report on Aveanna Healthcare (AVAH)
- Are Ocugen or Amarin Good Penny Stocks to Buy?
- Are These 2 Fintechs A Buy After Q2 Earnings?
- Is Fisker Ready to Re-Emerge as the Tesla Killer?
- Chipotle is Cooking Up Another Run at $2,000
- Dick's Sporting Goods Lifted By Institutional Shift
- 免费获取StockNews.com关于Aveanna Healthcare(Avah)的研究报告
- Ocugen或Amarin是值得购买的便士股票吗？
- 这两家金融科技公司是在第二季度盈利后买入的吗？
- 菲斯克准备好重新成为特斯拉杀手了吗？
- Chipotle正在酝酿另一轮2000美元的涨势
- 迪克的体育用品被制度变迁提振
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
接受Aveanna Healthcare Daily的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Aveanna Healthcare和相关公司的最新新闻和分析师评级的每日简要摘要。